Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 28
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Intracellular targeting of CD44+ cells with self-assembling, protein only nanoparticles

  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Gener, Petra|||0000-0002-2250-570X
  • Tatkiewicz, Witold
  • Abasolo, Ibane|||0000-0001-5970-6276
  • Ratera Bastardas, Imma|||0000-0002-1464-9789
  • Veciana i Miró, Jaume|||0000-0003-1023-9923
  • Schwartz, Simon|||0000-0001-8297-7971
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
CD44 is a multifunctional cell surface protein involved in proliferation and differentiation, angiogenesis and signaling. The expression of CD44 is up-regulated in several types of human tumors and particularly in cancer stem cells, representing an appealing target for drug delivery in the treatment of cancer. We have explored here several protein ligands of CD44 for the construction of self-assembling modular proteins designed to bind and internalize target cells. Among five tested ligands, two of them (A5G27 and FNI/II/V) drive the formation of protein-only, ring-shaped nanoparticles of about 14 nm that efficiently bind and penetrate CD44(+) cells by an endosomal route. The potential of these newly designed nanoparticles is evaluated regarding the need of biocompatible nanostructured materials for drug delivery in CD44-linked conditions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Production of functional inclusion bodies in endotoxin-free Escherichia coli

  • Rueda, Fabián
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Mamat, Uwe
  • Wilke, Kathleen
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Villaverde, Antonio|||0000-0002-2615-4521
Escherichia coli is the workhorse for gene cloning and production of soluble recombinant proteins in both biotechnological and biomedical industries. The bacterium is also a good producer of several classes of protein-based self-assembling materials such as inclusion bodies (IBs). Apart from being a relatively pure source of protein for in vitro refolding, IBs are under exploration as functional, protein-releasing materials in regenerative medicine and protein replacement therapies. Endotoxin removal is a critical step for downstream applications of therapeutic proteins. The same holds true for IBs as they are often highly contaminated with cell-wall components of the host cells. Here, we have investigated the production of IBs in a recently developed endotoxin-free E. coli strain. The characterization of IBs revealed this mutant as a very useful cell factory for the production of functional endotoxin-free IBs that are suitable for the use at biological interfaces without inducing endotoxic responses in human immune cells.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Expanding the recombinant protein quality in Lactococcus lactis

  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Rueda, Fabián L.
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Ruiz-Ávila, Luis
  • Bosser, Ramon
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
Background: Escherichia coli has been a main host for the production of recombinant proteins of biomedical interest, but conformational stress responses impose severe bottlenecks that impair the production of soluble, proteolytically stable versions of many protein species. In this context, emerging Generally Recognized As Safe (GRAS) bacterial hosts provide alternatives as cell factories for recombinant protein production, in which limitations associated to the use of Gram-negative microorganisms might result minimized. Among them, Lactic Acid Bacteria and specially Lactococcus lactis are Gram-positive GRAS organisms in which recombinant protein solubility is generically higher and downstream facilitated, when compared to E. coli. However, deep analyses of recombinant protein quality in this system are still required to completely evaluate its performance and potential for improvement. - Results : we have explored here the conformational quality (through specific fluorescence emission) and solubility of an aggregation-prone GFP variant (VP1GFP) produced in L. lactis. In this context, our results show that parameters such as production time, culture conditions and growth temperature have a dramatic impact not only on protein yield, but also on protein solubility and conformational quality, that are particularly favored under fermentative metabolism. - Conclusions: metabolic regime and cultivation temperature greatly influence solubility and conformational quality of an aggregation-prone protein in L. lactis. Specifically, the present study proves that anaerobic growth is the optimal condition for recombinant protein production purposes. Besides, growth temperature plays an important role regulating both protein solubility and conformational quality. Additionally, our results also prove the great versatility for the manipulation of this bacterial system regarding the improvement of functionality, yield and quality of recombinant proteins in this species. These findings not only confirm L. lactis as an excellent producer of recombinant proteins but also reveal room for significant improvement by the exploitation of external protein quality modulators.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeting low-density lipoprotein receptors with protein-only nanoparticles

  • Xu, Zhikun
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Álamo, Patricia|||0000-0003-0510-5701
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
Low-density lipoprotein receptors (LDLR) are appealing cell surface targets in drug delivery, as they are expressed in the blood-brain barrier (BBB) endothelium and are able to mediate transcytosis of functionalized drugs for molecular therapies of the central nervous system (CNS). On the other hand, brain-targeted drug delivery is currently limited, among others, by the poor availability of biocompatible vehicles, as most of the nanoparticles under development as drug carriers pose severe toxicity issues. In this context, protein nanoparticles offer functional versatility, easy and cost-effective bioproduction, and full biocompatibility. In this study, we have designed and characterized several chimerical proteins containing different LDLR ligands, regarding their ability to bind and internalize target cells and to self-organize as viral mimetic nanoparticles of about 18 nm in diameter. While the self-assembling of LDLR-binding proteins as nanoparticles positively influences cell penetration in vitro, the nanoparticulate architecture might be not favoring BBB crossing in vivo. These findings are discussed in the context of the use of nanostructured materials as vehicles for the systemic treatment of CNS diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A novel bio-functional material based on mammalian cell aggresomes

  • Rodríguez-Carmona, Escarlata
  • Mendoza Moreno, Rosa|||0000-0002-0488-4814
  • Ruiz Cánovas, Eugènia
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Abasolo, Ibane|||0000-0001-5970-6276
  • Schwartz, Simon|||0000-0001-8297-7971
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Corchero Nieto, José Luis|||0000-0002-6109-144X
Aggresomes are protein aggregates found in mammalian cells when the intracellular protein degradation machinery is over-titered. Despite that they abound in cells producing recombinant proteins of biomedical and biotechnological interest, the physiological roles of these protein clusters and the functional status of the embedded proteins remain basically unexplored. In this work, we have determined for the first time that, like in bacterial inclusion bodies, deposition of recombinant proteins into aggresomes does not imply functional inactivation. As a model, human α-galactosidase A (GLA) has been expressed in mammalian cells as enzymatically active, mechanically stable aggresomes showing higher thermal stability than the soluble GLA version. Since aggresomes are easily produced and purified, we propose these particles as novel functional biomaterials with potential as carrier-free, self-immobilized catalyzers in biotechnology and biomedicine.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Bottom-up instructive quality control in the biofabrication of smart protein materials

  • Rueda, Fabián
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Conchillo-Solé, Oscar|||0000-0003-4266-246X
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Cubarsi, Rafael
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Vázquez, Esther|||0000-0003-1052-0424
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Villaverde, Antonio|||0000-0002-2615-4521
The impact of cell factory quality control on material properties is a neglected but critical issue in the fabrication of protein biomaterials, which are unique in merging structure and function. The molecular chaperoning of protein conformational status is revealed here as a potent molecular instructor of the macroscopic properties of self-assembling, cell-targeted protein nanoparticles, including biodistribution upon in vivo administration.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Conformational and functional variants of CD44-targeted protein nanoparticles bio-produced in bacteria

  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Fernández Caparrós, Yolanda
  • Foradada Felip, Laia|||0000-0002-0589-4360
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Conchillo-Solé, Oscar|||0000-0003-4266-246X
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Xu, Zhikun
  • Roldán, Mónica
  • Villegas Hernández, Sandra|||0000-0001-8644-4304
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Schwartz, Simon|||0000-0001-8297-7971
  • Rinas, Ursula
  • Daura i Ribera, Xavier|||0000-0001-9235-6730
  • Abasolo, Ibane|||0000-0001-5970-6276
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Biofabrication is attracting interest as a means to produce nanostructured functional materials because of its operational versatility and full scalability. Materials based on proteins are especially appealing, as the structure and functionality of proteins can be adapted by genetic engineering. Furthermore, strategies and tools for protein production have been developed and refined steadily for more than 30 years. However, protein conformation and therefore activity might be sensitive to production conditions. Here, we have explored whether the downstream strategy influences the structure and biological activities, in vitro and in vivo, of a self-assembling, CD44-targeted protein-only nanoparticle produced in Escherichia coli. This has been performed through the comparative analysis of particles built from soluble protein species or protein versions obtained by in vitro protein extraction from inclusion bodies, through mild, non-denaturing procedures. These methods have been developed recently as a convenient alternative to the use of toxic chaotropic agents for protein resolubilization from protein aggregates. The results indicate that the resulting material shows substantial differences in its physicochemical properties and its biological performance at the systems level, and that its building blocks are sensitive to the particular protein source.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Functional protein-based nanomaterial produced in GRAS microorganism, a new platform for biotechnology

  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Parés, Sílvia
  • Giro Paradell, Irene
  • Tatkiewicz, Witold I.|||0000-0003-1349-2174
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Ratera Bastardas, Imma|||0000-0002-1464-9789
  • Natalello, Antonino|||0000-0002-1489-272X
  • Cubarsi, Rafael
  • Veciana i Miró, Jaume|||0000-0003-1023-9923
  • Bach, Àlex|||0000-0001-6804-2002
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Arís i Giralt, Anna|||0000-0001-7830-888X
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
Inclusion bodies (IBs) are protein-based nanoparticles formed in Escherichia coli through stereospecific aggregation processes during the overexpression of recombinant proteins. In the last years, it has been shown that IBs can be used as nanostructured biomaterials to stimulate mammalian cell attachment, proliferation, and differentiation. In addition, these nanoparticles have also been explored as natural delivery systems for protein replacement therapies. Although the production of these protein-based nanomaterials in E. coli is economically viable, important safety concerns related to the presence of endotoxins in the products derived from this microorganism need to be addressed. Lactic acid bacteria (LAB) are a group of food-grade microorganisms that have been classified as safe by biologically regulatory agencies. In this context, we have demonstrated herein, for the first time, the production of fully functional, IB-like protein nanoparticles in LAB. These nanoparticles have been fully characterized using a wide range of techniques, including field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), Fourier transform infrared (FTIR) spectroscopy, zymography, cytometry, confocal microscopy, and wettability and cell coverage measurements. Our results allow us to conclude that these materials share the main physico-chemical characteristics with IBs from E. coli and moreover are devoid of any harmful endotoxin contaminant. These findings reveal a new platform for the production of protein-based safe products with high pharmaceutical interest.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4⁺ colorectal cancer models

  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Álamo, Patricia|||0000-0003-0510-5701
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Sala Faig, Rita
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Pavón Ribas, Miguel Ángel
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • Trias Folch, Manuel
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
Unliganded drug-nanoconjugates accumulate passively in the tumor whereas liganded nanoconjugates promote drug internalization in tumor cells via endocytosis and increase antitumor efficacy. Whether or not tumor cell internalization associates with enhanced tumor uptake is still under debate. We here compared tumor uptake of T22-GFP-H6, a liganded protein carrier targeting the CXCR4 receptor, and the unliganded GFP-H6 carrier in subcutaneous and metastatic colorectal cancer models. T22-GFP-H6 had a higher tumor uptake in primary tumor and metastatic foci than GFP-H6, with no biodistribution or toxicity on normal tissues. T22-GFP-H6 was detected in target CXCR4+ tumor cell cytosol whereas GFP-H6 was detected in tumor stroma. SDF1-α co-administration switched T22-GFP-H6 internalization from CXCR4+ tumor epithelial cells to the stroma. Therefore, the incorporation of a targeting ligand promotes selective accumulation of the nanocarrier inside target tumor cells while increasing whole tumor uptake in a CXCR4-dependent manner, validating T22-GFP-H6 as a CXCR4-targeted drug carrier.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Nanostructured recombinant cytokines, A highly stable alternative to short-lived prophylactics

  • Torrealba, Debora
  • Parra, David|||0000-0002-3634-7087
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Vallejos Vidal, Eva Carolina|||0000-0002-3091-2700
  • Yero, Daniel|||0000-0002-6234-4082
  • Gibert, Isidre|||0000-0003-1442-2258
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Roher Armentia, Nerea|||0000-0002-6659-4038
Cytokines have been widely used as adjuvants and therapeutic agents in treatments of human diseases. Despite their recognized potential as drugs, the medical use of cytokines has considerable drawbacks, mainly related to their low stability and short half-life. Such intrinsic limitations imply the administration of high doses, often prompting toxicity, undesirable side effects and greater production costs. Here, we describe a new category of mechanically stable nanostructured cytokines (TNFα and CCL4/MIP-1β) that resist harsh physicochemical conditions in vitro (pH and temperature), while maintaining functionality. These bio-functional materials are produced in recombinant cell factories through cost-effective and fully scalable processes. Notably, we demonstrate their prophylactic potential in vivo showing they protect zebrafish from a lethal infection by Pseudomonas aeruginosa.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs

  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Fernández Caparrós, Yolanda
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Mendoza Moreno, Rosa|||0000-0002-0488-4814
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Álamo, Patricia|||0000-0003-0510-5701
  • Toledo-Rubio, Verónica
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Vázquez, Esther|||0000-0003-1052-0424
  • Schwartz, Simon|||0000-0001-8297-7971
  • Abasolo, Ibane|||0000-0001-5970-6276
  • Corchero Nieto, José Luis|||0000-0002-6109-144X
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
In the human endocrine system many protein hormones including urotensin, glucagon, obestatin, bombesin and secretin, among others, are supplied from amyloidal secretory granules. These granules form part of the so called functional amyloids, which within the whole aggregome appear to be more abundant than formerly believed. Bacterial inclusion bodies (IBs) are non-toxic, nanostructured functional amyloids whose biological fabrication can be tailored to render materials with defined biophysical properties. Since under physiological conditions they steadily release their building block protein in a soluble and functional form, IBs are considered as mimetics of endocrine secretory granules. We have explored here if the in vivo implantation of functional IBs in a given tissue would represent a stable local source of functional protein. Upon intratumoral injection of bacterial IBs formed by a potent protein ligand of CXCR4 we have observed high stability and prevalence of the material in absence of toxicity, accompanied by apoptosis of CXCR4+ cells and tumor ablation. Then, the local immobilization of bacterial amyloids formed by therapeutic proteins in tumors or other tissues might represent a promising strategy for a sustained local delivery of protein drugs by mimicking the functional amyloidal architecture of the mammals' endocrine system.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Recombinant pharmaceuticals from microbial cells, a 2015 update

  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Martín, Lucas
  • Mangues, Ramon|||0000-0003-2661-9525
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to protein absence or malfunction. Since these pathologies cannot be yet regularly treated by gene therapy, the administration of functional proteins produced ex vivo is required. As both protein extraction from natural producers and chemical synthesis undergo inherent constraints that limit regular large-scale production, recombinant DNA technologies have rapidly become a choice for therapeutic protein production. The spectrum of organisms exploited as recombinant cell factories has expanded from the early predominating Escherichia coli to alternative bacteria, yeasts, insect cells and especially mammalian cells, which benefit from metabolic and protein processing pathways similar to those in human cells. Up to date, around 650 protein drugs have been worldwide approved, among which about 400 are obtained by recombinant technologies. Other 1300 recombinant pharmaceuticals are under development, with a clear tendency towards engineered versions with improved performance and new functionalities regarding the conventional, plain protein species. This trend is exemplified by the examination of the contemporary protein-based drugs developed for cancer treatment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms

  • Torrealba, Debora
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Mamat, Uwe
  • Wilke, Kathleen
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Roher Armentia, Nerea|||0000-0002-6659-4038
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
The control of infectious diseases is a major current challenge in intensive aquaculture. Most commercial vaccines are based on live attenuated or inactivated pathogens that are usually combined with adjuvants, oil emulsions being as the most widely used for vaccination in aquaculture. Although effective, the use of these oil emulsions is plagued with important side effects. Thus, the development of alternative safer and cost-effective immunostimulants and adjuvants is highly desirable. Here we have explored the capacity of inclusion bodies produced in bacteria to immunostimulate and protect fish against bacterial infections. Bacterial inclusion bodies are highly stable, non-toxic protein-based biomaterials produced through fully scalable and low-cost bio-production processes. The present study shows that the composition and structured organization of inclusion body components (protein, lipopolysaccharide, peptidoglycan, DNA and RNA) make these protein biomaterials excellent immunomodulators able to generically protect fish against otherwise lethal bacterial challenges. The results obtained in this work provide evidence that their inherent nature makes bacterial inclusion bodies exceptionally attractive as immunostimulants and this opens the door to the future exploration of this biomaterial as an alternative adjuvant for vaccination purposes in veterinary.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Trehalose polyphleates, external cell wall lipids in Mycobacterium abscessus, are associated with the formation of clumps with cording morphology, which have been associated with virulence

  • Llorens Fons, Marta|||0000-0002-5154-1398
  • Pérez-Trujillo, Míriam|||0000-0002-6919-7417
  • Julián, Esther|||0000-0002-6558-3978
  • Brambilla, Cecilia
  • Alcaide, Fernando|||0000-0002-4097-1499
  • Byrd, Thomas F.
  • Luquin Fernandez, Marina de la Milagrosa|||0000-0002-6015-3282
Mycobacterium abscessus is a reemerging pathogen that causes pulmonary diseases similar to tuberculosis, which is caused by Mycobacterium tuberculosis. When grown in agar medium, M. abscessus strains generate rough (R) or smooth colonies (S). R morphotypes are more virulent than S morphotypes. In searching for the virulence factors responsible for this difference, R morphotypes have been found to form large aggregates (clumps) that, after being phagocytozed, result in macrophage death. Furthermore, the aggregates released to the extracellular space by damaged macrophages grow, forming unphagocytosable structures that resemble cords. In contrast, bacilli of the S morphotype, which do not form aggregates, do not damage macrophages after phagocytosis and do not form cords. Cording has also been related to the virulence of M. tuberculosis. In this species, the presence of mycolic acids and surface-exposed cell wall lipids has been correlated with the formation of cords. The objective of this work was to study the roles of the surface-exposed cell wall lipids and mycolic acids in the formation of cords in M. abscessus. A comparative study of the pattern and structure of mycolic acids was performed on R (cording) and S (non-cording) morphotypes derived from the same parent strains, and no differences were observed between morphotypes. Furthermore, cords formed by R morphotypes were disrupted with petroleum ether (PE), and the extracted lipids were analyzed by thin layer chromatography, nuclear magnetic resonance spectroscopy and mass spectrometry. Substantial amounts of trehalose polyphleates (TPP) were recovered as major lipids from PE extracts, and images obtained by transmission electron microscopy suggested that these lipids are localized to the external surfaces of cords and R bacilli. The structure of M. abscessus TPP was revealed to be similar to those previously described in Mycobacterium smegmatis. Although the exact role of TPP is unknown, our results demonstrated that TPP are not toxic by themselves and have a function in the formation of clumps and cords in M. abscessus, thus playing an important role in the pathogenesis of this species.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mycobacteria clumping increase their capacity to damage macrophages

  • Brambilla, Cecilia
  • Llorens Fons, Marta|||0000-0002-5154-1398
  • Julián, Esther|||0000-0002-6558-3978
  • Noguera-Ortega, Estela|||0000-0001-6507-0673
  • Tomàs Martínez, Cristina
  • Pérez-Trujillo, Míriam|||0000-0002-6919-7417
  • Byrd, Thomas F.
  • Alcaide, Fernando|||0000-0002-4097-1499
  • Luquin Fernandez, Marina de la Milagrosa|||0000-0002-6015-3282
The rough morphotypes of non-tuberculous mycobacteria have been associated with the most severe illnesses in humans. This idea is consistent with the fact that Mycobacterium tuberculosis presents a stable rough morphotype. Unlike smooth morphotypes, the bacilli of rough morphotypes grow close together, leaving no spaces among them and forming large aggregates (clumps). Currently, the initial interaction of macrophages with clumps remains unclear. Thus, we infected J774 macrophages with bacterial suspensions of rough morphotypes of M. abscessus containing clumps and suspensions of smooth morphotypes, primarily containing isolated bacilli. Using confocal laser scanning microscopy and electron microscopy, we observed clumps of at least five rough-morphotype bacilli inside the phagocytic vesicles of macrophages at 3 h post-infection. These clumps grew within the phagocytic vesicles, killing 100% of the macrophages at 72 h post-infection, whereas the proliferation of macrophages infected with smooth morphotypes remained unaltered at 96 h post-infection. Thus, macrophages phagocytose large clumps, exceeding the bactericidal capacities of these cells. Furthermore, proinflammatory cytokines and granuloma-like structures were only produced by macrophages infected with rough morphotypes. Thus, the present study provides a foundation for further studies that consider mycobacterial clumps as virulence factors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lactic acid bacteria, reviewing the potential of a promising delivery live vector for biomedical purposes

  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
Lactic acid bacteria (LAB) have a long history of safe exploitation by humans, being used for centuries in food production and preservation and as probiotic agents to promote human health. Interestingly, some species of these Gram-positive bacteria, which are generally recognized as safe organisms by the US Food and Drug Administration (FDA), are able to survive through the gastrointestinal tract (GIT), being capable to reach and colonize the intestine, where they play an important role. Besides, during the last decades, an important effort has been done for the development of tools to use LAB as microbial cell factories for the production of proteins of interest. Given the need to develop effective strategies for the delivery of prophylactic and therapeutic molecules, LAB have appeared as an appealing option for the oral, intranasal and vaginal delivery of such molecules. So far, these genetically modified organisms have been successfully used as vehicles for delivering functional proteins to mucosal tissues in the treatment of many different pathologies including GIT related pathologies, diabetes, cancer and viral infections, among others. Interestingly, the administration of such microorganisms would suppose a significant decrease in the production cost of the treatments agents since being live organisms, such vectors would be able to autonomously amplify and produce and deliver the protein of interest. In this context, this review aims to provide an overview of the use of LAB engineered as a promising alternative as well as a safety delivery platform of recombinant proteins for the treatment of a wide range of diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Functional inclusion bodies produced in the yeast Pichia pastoris

  • Rueda, Fabián
  • Gasser, Brigitte|||0000-0003-2881-6370
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Roldán, Mónica
  • Villegas Hernández, Sandra|||0000-0001-8644-4304
  • Puxbaum, Verena
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Mattanovich, Diethard|||0000-0002-0907-4167
  • Villaverde, Antonio|||0000-0002-2615-4521
Background: Bacterial inclusion bodies (IBs) are non-toxic protein aggregates commonly produced in recombinant bacteria. They are formed by a mixture of highly stable amyloid-like fibrils and releasable protein species with a significant extent of secondary structure, and are often functional. As nano structured materials, they are gaining biomedical interest because of the combination of submicron size, mechanical stability and biological activity, together with their ability to interact with mammalian cell membranes for subsequent cell penetration in absence of toxicity. Since essentially any protein species can be obtained as IBs, these entities, as well as related protein clusters (e.g., aggresomes), are being explored in biocatalysis and in biomedicine as mechanically stable sources of functional protein. One of the major bottlenecks for uses of IBs in biological interfaces is their potential contamination with endotoxins from producing bacteria. - Results: to overcome this hurdle, we have explored here the controlled production of functional IBs in the yeast Pichia pastoris (Komagataella spp.), an endotoxin-free host system for recombinant protein production, and determined the main physicochemical and biological traits of these materials. Quantitative and qualitative approaches clearly indicate the formation of IBs inside yeast, similar in morphology, size and biological activity to those produced in E. coli, that once purified, interact with mammalian cell membranes and penetrate cultured mammalian cells in absence of toxicity. - Conclusions: structurally and functionally similar from those produced in E. coli, the controlled production of IBs in P. pastoris demonstrates that yeasts can be used as convenient platforms for the biological fabrication of self-organizing protein materials in absence of potential endotoxin contamination and with additional advantages regarding, among others, post-translational modifications often required for protein functionality.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli

  • Rueda, Fabian
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Vázquez, Esther|||0000-0003-1052-0424
  • Rinas, Ursula
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Mamat, Uwe
  • Mangues, Ramon|||0000-0003-2661-9525
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Villaverde, Antonio|||0000-0002-2615-4521
Background: production of recombinant drugs in process-friendly endotoxin-free bacterial factories targets to a lessened complexity of the purification process combined with minimized biological hazards during product application. The development of nanostructured recombinant materials in innovative nanomedical activities expands such a need beyond plain functional polypeptides to complex protein assemblies. While Escherichia coli has been recently modified for the production of endotoxin-free proteins, no data has been so far recorded regarding how the system performs in the fabrication of smart nanostructured materials. - Results: we have here explored the nanoarchitecture and in vitro and in vivo functionalities of CXCR4-targeted, self-assembling protein nanoparticles intended for intracellular delivery of drugs and imaging agents in colorectal cancer. Interestingly, endotoxin-free materials exhibit a distinguishable architecture and altered size and target cell penetrability than counterparts produced in conventional E. coli strains. These variant nanoparticles show an eventual proper biodistribution and highly specific and exclusive accumulation in tumor upon administration in colorectal cancer mice models, indicating a convenient display and function of the tumor homing peptides and high particle stability under physiological conditions. - Discussion: the observations made here support the emerging endotoxin-free E. coli system as a robust protein material producer but are also indicative of a particular conformational status and organization of either building blocks or oligomers. This appears to be promoted by multifactorial stress-inducing conditions upon engineering of the E. coli cell envelope, which impacts on the protein quality control of the cell factory.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CXCR4+-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis

  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Saccardo, Paolo|||0000-0002-3092-1404
  • Roldán, M.
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Cubarsi, Rafael
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Villaverde, Antonio|||0000-0002-2615-4521
Aim: Lactococcus lactis is a Gram-positive (endotoxin-free) food-grade bacteria exploited as alternative to Escherichia coli for recombinant protein production. We have explored here for the first time the ability of this platform as producer of complex, self-assembling protein materials. Materials & methods: Biophysical properties, cell penetrability and in vivo biodistribution upon systemic administration of tumor-targeted protein nanoparticles produced in L. lactis have been compared with the equivalent material produced in E. coli. Results: Protein nanoparticles have been efficiently produced in L. lactis, showing the desired size, internalization properties and biodistribution. Conclusion: In vitro and in vivo data confirm the potential and robustness of the production platform, pointing out L. lactis as a fascinating cell factory for the biofabrication of protein materials intended for therapeutic applications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticles

  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Crosas, Eva|||0000-0002-2408-0071
  • Cubarsi, Rafael
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Saccardo, Paolo|||0000-0002-3092-1404
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Rueda, Fabian
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Mangues, Ramon|||0000-0003-2661-9525
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Self-assembling proteins are gaining attention as building blocks for application-tailored nanoscale materials. This is mostly due to the biocompatibility, biodegradability, and functional versatility of peptide chains. Such a potential for adaptability is particularly high in the case of recombinant proteins, which are produced in living cells and are suitable for genetic engineering. However, how the cell factory itself and the particular protein folding machinery influence the architecture and function of the final material is still poorly explored. In this study we have used diverse analytical approaches, including small-angle X-ray scattering (SAXS) and field emission scanning electron microscopy (FESEM) to determine the fine architecture and geometry of recombinant, tumor-targeted protein nanoparticles of interest as drug carriers, constructed on a GFP-based modular scheme. A set of related oligomers were produced in alternative Escherichia coli strains with variant protein folding networks. This resulted in highly regular populations of morphometric types, ranging from 2.4 to 28 nm and from spherical- to rod-shaped materials. These differential geometric species, whose relative proportions were determined by the features of the producing strain, were found associated with particular fluorescence emission, cell penetrability and receptor specificity profiles. Then, nanoparticles with optimal properties could be analytically identified and further isolated from producing cells for use. The cell's protein folding machinery greatly modulates the final geometry reached by the constructs, which in turn defines the key parameters and biological performance of the material.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The fusogenic peptide HA2 impairs selectivity of CXCR4-targeted protein nanoparticles

  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Mattanovich, M.
  • Cazzanelli, P.
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Conchillo-Solé, Oscar|||0000-0003-4266-246X
  • Cortés López, Francisco
  • Daura i Ribera, Xavier|||0000-0001-9235-6730
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
We demonstrate here that the genetic incorporation of the fusogenic peptide HA2 into a CXCR4-targeted protein nanoparticle dramatically reduces the specificity of the interaction between nanoparticles and cell receptors, a factor to be considered when designing tumor-homing drug vehicles displaying endosomal-escape agents. The loss of specificity is concomitant with enhanced cell penetrability.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4+ colorectal cancer stem cells

  • Serna, Naroa|||0000-0001-5682-8198
  • Álamo, Patricia|||0000-0003-0510-5701
  • Ramesh, Prashanthi
  • Vinokurova, Daria
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Medema, Jan Paul
Current therapies fail to eradicate colorectal Cancer Stem Cells (CSCs). One of the proposed reasons for this failure is the selection, by chemotherapy exposure, of resistant cells responsible for tumor recurrence. In this regard, CXCR4 overexpression in tumor associates with resistance and poor prognosis in colorectal cancer (CRC) patients. In this study, the effectiveness of engineered CXCR4-targeted self-assembling toxin nanoparticles has been explored in the selective killing of CXCR4 human colon-CSCs compared to 5-Fluorouracil and Oxaliplatin, both classical CRC chemotherapeutic agents. To assess this, 3D spheroid colon-CSCs cultures directly derived from CRC patients and CRC-CSC spheroid-derived tumor mouse models were developed. In these animal models, nanostructured toxins show highly selective induction of pyroptosis in the absence of apoptosis, thus having a great potential to overcome tumor resistance, since the same tumor models show resistance to chemotherapeutics. Results set the basis for further development of more efficient therapies focused on selective CXCR4 CSCs elimination activating non-apoptotic mechanisms and represent a pre-clinical proof of concept for the use of CSCs-targeted nanostructured toxins as protein drugs for CRC therapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Draft Genome Sequence of Mycobacterium brumae ATCC 51384

  • D'Auria, Giuseppe|||0000-0003-0672-2541
  • Torrents, Eduard|||0000-0002-3010-1609
  • Luquin Fernandez, Marina de la Milagrosa|||0000-0002-6015-3282
  • Comas, I.|||0000-0001-5504-9408
  • Julián, Esther|||0000-0002-6558-3978
Here, we report the draft genome sequence of Mycobacterium brumae type strain ATCC 51384. This is the first draft genome sequence of M. brumae, a nonpathogenic, rapidly growing, nonchromogenic mycobacterium, with immunotherapeutic capacities.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Protein-based therapeutic killing for cancer therapies

  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Díaz, Raquel
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
The treatment of some high-incidence human diseases is based on therapeutic cell killing. In cancer this is mainly achieved by chemical drugs that are systemically administered to reach effective toxic doses. As an innovative alternative, cytotoxic proteins identified in nature can be adapted as precise therapeutic agents. For example, individual toxins and venom components, proapoptotic factors, and antimicrobial peptides from bacteria, animals, plants, and humans have been engineered as highly potent drugs. In addition to the intrinsic cytotoxic activities of these constructs, their biological fabrication by DNA recombination allows the recruitment, in single pharmacological entities, of diverse functions of clinical interest such as specific cell-surface receptor binding, self-activation, and self-assembling as nanoparticulate materials, with wide applicability in cell-targeted oncotherapy and theragnosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Improving biomaterials imaging for nanotechnology, rapid methods for protein localization at ultrastructural level

  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
The preparation of biological samples for electron microscopy is material- and time-consuming because it is often based on long protocols that also may produce artifacts. Protein labeling for transmission electron microscopy (TEM) is such an example, taking several days. However, for protein-based nanotechnology, high resolution imaging techniques are unique and crucial tools for studying the spatial distribution of these molecules, either alone or as components of biomaterials. In this paper, we tested two new short methods of immunolocalization for TEM, and compared them with a standard protocol in qualitative and quantitative approaches by using four protein-based nanoparticles. We reported a significant increase of labeling per area of nanoparticle in both new methodologies (H = 19.811; p < 0.001) with all the model antigens tested: GFP (H = 22.115; p < 0.001), MMP-2 (H = 19.579; p < 0.001), MMP-9 (H = 7.567; p < 0.023), and IFN-γ (H = 62.110; p < 0.001). We also found that the most suitable protocol for labeling depends on the nanoparticle's tendency to aggregate. Moreover, the shorter methods reduce artifacts, time (by 30%), residues, and reagents hindering, losing, or altering antigens, and obtaining a significant increase of protein localization (of about 200%). Overall, this study makes a step forward in the development of optimized protocols for the nanoscale localization of peptides and proteins within new biomaterials.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs

  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sala, Rita
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Roldán, Mònica
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Loading capacity and drug leakage from vehicles during circulation in blood is a major concern when developing nanoparticle-based cell-targeted cytotoxics. To circumvent this potential issue it would be convenient the engineering of drugs as self-delivered nanoscale entities, devoid of any heterologous carriers. In this context, we have here engineered potent protein toxins, namely segments of the diphtheria toxin and the Pseudomonas aeruginosa exotoxin as self-assembling, self-delivered therapeutic materials targeted to CXCR4 cancer stem cells. The systemic administration of both nanostructured drugs in a colorectal cancer xenograft mouse model promotes efficient and specific local destruction of target tumor tissues and a significant reduction of the tumor volume. This observation strongly supports the concept of intrinsically functional protein nanoparticles, which having a dual role as drug and carrier, are designed to be administered without the assistance of heterologous vehicles.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Protein nanoparticles are nontoxic, tuneable cell stressors

  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Roldán, Mònica
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Serna, Naroa|||0000-0001-5682-8198
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Azzoni, Adriano Rodrigues|||0000-0003-0696-4663
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Aim: nanoparticle-cell interactions can promote cell toxicity and stimulate particular behavioral patterns, but cell responses to protein nanomaterials have been poorly studied. - Results: by repositioning oligomerization domains in a simple, modular self-assembling protein platform, we have generated closely related but distinguishable homomeric nanoparticles. Composed by building blocks with modular domains arranged in different order, they share amino acid composition. These materials, once exposed to cultured cells, are differentially internalized in absence of toxicity and trigger distinctive cell adaptive responses, monitored by the emission of tubular filopodia and enhanced drug sensitivity. - Conclusion: the capability to rapidly modulate such cell responses by conventional protein engineering reveals protein nanoparticles as tuneable, versatile and potent cell stressors for cell-targeted conditioning.